MedTech Solutions (WAR:MDT) Cyclically Adjusted PS Ratio: (As of Jul. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:MDT MedTech Solutions SA WAR:MDT
37 GF Score
Price zł0.29
GF Value zł0.04
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is MedTech Solutions Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


MedTech Solutions  (WAR:MDT) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


MedTech Solutions Cyclically Adjusted PS Ratio Related Terms


MedTech Solutions Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for MedTech Solutions's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedTech Solutions Cyclically Adjusted PS Ratio Chart

MedTech Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.62

MedTech Solutions Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.78 0.00 0.62 0.00

WAR:MDT vs AMZN, BABA, PDD: Cyclically Adjusted PS Ratio Comparison

For the Internet Retail subindustry, MedTech Solutions's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedTech Solutions Cyclically Adjusted PS Ratio vs Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, MedTech Solutions's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where MedTech Solutions's Cyclically Adjusted PS Ratio falls into.


WAR:MDT
37GF Score
MedTech Solutions SA WAR:MDT
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedTech Solutions Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

MedTech Solutions's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, MedTech Solutions's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0/163.0700*163.0700
=0.000

Current CPI (Mar. 2026) = 163.0700.

MedTech Solutions Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.015 99.552 0.025
201609 1.512 99.064 2.489
201612 0.090 100.366 0.146
201703 0.174 101.018 0.281
201706 0.069 101.180 0.111
201709 0.050 101.343 0.080
201712 0.017 102.564 0.027
201803 0.020 102.564 0.032
201806 0.023 103.378 0.036
201809 0.017 103.378 0.027
201812 0.014 103.785 0.022
201903 0.015 104.274 0.023
201906 0.010 105.983 0.015
201909 0.008 105.983 0.012
201912 0.008 107.123 0.012
202003 0.007 109.076 0.010
202006 0.003 109.402 0.004
202009 0.007 109.320 0.010
202012 0.007 109.565 0.010
202103 0.006 112.658 0.009
202106 0.002 113.960 0.003
202109 0.012 115.588 0.017
202112 0.038 119.088 0.052
202203 0.000 125.031 0.000
202206 0.000 131.705 0.000
202209 0.000 135.531 0.000
202212 0.003 139.113 0.004
202303 0.002 145.950 0.002
202306 0.009 147.009 0.010
202309 0.020 146.113 0.022
202312 0.040 147.741 0.044
202403 0.034 149.044 0.037
202406 0.033 150.997 0.036
202409 0.012 153.439 0.013
202412 0.010 154.660 0.011
202503 0.004 157.021 0.004
202506 0.001 157.509 0.001
202509 0.000 158.000 0.000
202512 0.003 158.320 0.003
202603 0.000 163.070 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is MedTech Solutions (WAR:MDT) Overvalued in 2026?

Based on GuruFocus' analysis, MedTech Solutions stock appears to be overvalued. The current stock price of zł0.29 is trading 625% above its estimated GF Value™ of zł0.04. GuruFocus considers MedTech Solutions to be Significantly Overvalued.

Key valuation signals for WAR:MDT:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: zł0.04 vs. price of zł0.29 (625% above fair value)
  • GF Score™: 37/100 with 10 warning signs

No single metric tells the full story. See the WAR:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MedTech Solutions Business Description

Address Dluga 29, Warsaw, POL, 00-238
MedTech Solutions SA formerly E-shopping Group SA main activity is based on conducting business through its own e-shops that operate in the dropshipping sales model.
37GF Score

Get the complete analysis for WAR:MDT

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.29
Price
zł0.04
GF Value